Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment

Similar documents
HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in

ADVANCES IN MIGRAINE MANAGEMENT

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial

Clinical Policy: Triptans Reference Number: CP.HNMC.217 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal

COLUMBIA UNIVERSITY HEADACHE CENTER: NEW PATIENT QUESTIONNAIRE

How do we treat migraine? New SIGN Guidelines

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

Disclosures. Triptans for Kids 5/16/13

Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins

Treatments for migraine

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial

Triptan Quantity Limit

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

Page: 1 of 6. Aimovig (erenumab-aooe) injection, Ajovy (fremanezumab-vfrm) injection, Emgality (galcanezumab-gnim)

How could I be having migraine when I don't have a headache?

Headache Questionnaire

Understanding Migraines and Treatment Options. Simplified Diagnosis of Migraine. Migraine Prevalence American Migraine Study II

Anti-Migraine Agents

~ ColumbiaDoctors Adult New Patient Intake Form Patient Information

A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN

Head Pain Intake Form

TREXIMET UTILIZATION MANAGEMENT CRITERIA

Maxalt. Maxalt / Maxalt-MLT (rizatriptan) Description. Section: Prescription Drugs Effective Date: April 1, 2016

Update on Diagnosis and Management of Migraines

Treatment of Primary Headache Syndromes

Management of headache

Drug Name (select from list of drugs shown / provide drug information) Patient Information. Prescribing Physician

IMITREX UTILIZATION MANAGEMENT CRITERIA

Migranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description

Strategies in Migraine Care

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

Regulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1).

1. On how many days in the last 3 months did you miss work or school because of your headaches?

Triptans Quantity Limit Program Summary

Management options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

My patient s pain in the head, is a pain in Greg Jicha, M.D., Ph.D.

UTILIZATION MANAGEMENT CRITERIA

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

Understanding Migraines

Outline. Etiology. General information. Definition 4/13/2012

Approach to a Patient with Headache

Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE

ONZETRA XSAIL (sumatriptan) nasal powder

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

Headache A Practical Approach

disease or in clients who consume alcohol on a regular basis. bilirubin

General Patient Information Dr. David A. Branch, M.D.

MIGRAINE A MYSTERY HEADACHE

Clinical Learning Days November 10, 2017

SIGN on the pharmacological management of migraine

M0BCore Safety Profile. Pharmaceutical form(s)/strength: ordispersible tablet SE/H/PSUR/0022/002 Date of FAR:

Abortive Agents. Available Strengths. Formulary Limits. Tablet: 5mg, 10mg ODT: 5mg, 10 mg 25mg, 50mg, 100mg. 5mg/act, 20mg/act

ABORTIVE AGENTS. Average cost per 30 days. Form Limits SEROTONIN AGONISTS $ $ Reserved for treatment failure to either Sumatriptan PA; QL

23, 2005 RESIDENT PHYSICIAN:

Neurologic Disorders: Headache in Children

Clinical Policy: Sumatriptan Reference Number: CP.CPA.260 Effective Date: Last Review Date: Line of Business: Commercial

Farjam Farzam, M.D. Pediatric Neurology

COMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS

Core Safety Profile. Pharmaceutical form(s)/strength: Tablets and Oral lyophilisates (wafers) 5 and 10 mg NL/H/PSUR/0002/001 Date of FAR:

Acute Migraine Treatment in Adults

Headache. Headache Case. Migraine Headache. Eric Kraus, MD. Types» Without aura (common)» With aura (classic)

Page: 1 of 5. Sumatriptan Tablets and Nasal Spray (Imitrex) / sumatriptan and naproxen sodium (Treximet tablets)

Clinical Policy: Sumatriptan Reference Number: CP.HNMC.260 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal

10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD

Come prepared: What you can expect:

100% Effective Natural Hormone Treatment Menopause, Andropause And Other Hormone Imbalances Impair Healthy Healing In People Over The Age Of 30!

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

Headache. Section 1. Migraine headache. Clinical presentation

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description

SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection

The Pediatric Headache Handbook

Headache and Facial Pain. Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology

Migraine in Children. Germano Falcao, MD Pediatric Neurology 03/07/2014

10/31/2017 PRIMARY CARE AND HEADACHE DISCLOSURES WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Primary Care 67%

A PATIENT GUIDE FOR MANAGING PAIN

Package leaflet: Information for the user. Sumatriptan Amneal 100 mg tablets. sumatriptan

Migraine is a primary headache disorder ... REPORTS... Migraine: Diagnosis, Management, and New Treatment Options

Within 24 hours of treatment with another 5-HT 1 agonist, or an ergotaminecontaining

Department of Neurology Headache Questionnaire

ACUTE MIGRAINE: OLD AND NEW DRUGS JOHN ROBROCK MD FORT WILLIAM FAMILY HEALTH TEAM

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.

Faculty Disclosures. Learning Objectives. Acute Treatment Strategies

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

Reflections on NICE Headache Guideline. Dr Kay Kennis GPwSI in Headache, Bradford

IMITREX (sumatriptan) nasal spray Initial U.S. Approval: 1992

Neuroscience Institute Headache Center Intake Form. Please list ALL medications you are currently taking, including over-the-counter

Understanding. Migraine. Amy, diagnosed in 1989, with her family.

Headache Board Review: Pharmacology of Drugs, Guidelines and Evidence-Based

ALSUMA (sumatriptan injection) 6 mg/0.5 ml for subcutaneous use Initial U.S. Approval: 1992

Migraine Clinical Guideline

Sumatriptan Injection (Imitrex / Alsuma / Sumavel / Zembrace)

*** Drug Safety Alert ***

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Transcription:

Clinical Highlights 1. Headache is diagnosed by history and physical examination with limited need for imaging or laboratory tests. 2. Warning signs of possible disorder other than primary headache are: Subacute and/or progressive headaches that worsen over time (months) A new or different headache Any headache of maximum severity at onset A headache that wakens you from sleep Headache of new onset after age 50 Persistent headache precipitated by a Valsalva maneuver Evidence such as fever, hypertension, myalgias, weight loss or scalp tenderness suggesting a systemic disorder Presence of neurological signs that may suggest a secondary cause Seizures 3. Migraine-associated symptoms are often misdiagnosed as sinus headache by patients and providers. This has led to the underdiagnosis and treatment of migraine. 4. Appropriate pharmacological or analgesic treatment of acute headache should generally not exceed more than two days per week on a regular basis. More treatment other than this may result in medication-overuse chronic daily headaches. 5. Disability from headaches is an important issue for migraineurs. 6. All patients should be considered for prophylactic therapy. 7. Migraines occurring in association with menses and not responsive to standard cyclic prophylaxis may respond to hormonal prophylaxis with the use of estradiol patches or estrogen-containing contraceptives. 8. Women who have migraines with aura have a higher risk of stroke with the use of estrogen-containing contraceptives. Headaches occurring during perimenopause or after menopause may respond to hormonal therapy. 9. Most prophylactic medications should be started in a low dose and titrated to a therapeutic dose to minimize side effects and maintained at target dose for 8-12 weeks to obtain maximum efficacy. 10. Consider referral to addictive medicine program if appropriate. Treatment Goals 1. Increase the accurate diagnosis of headaches 2. Increase the functional status of those with migraine 3. Increase the rate of treatment plans or adherence to plan for mild, moderate and severe headaches for migraineurs 4. Reduce the use of opiates and barbiturates for the treatment of primary headache 5. Increase education for patients with primary headache 6. Increase appropriate prophylactic treatment based on headache type (i.e., migraine, cluster, menstrual-associated) 7. Increase appropriate acute and prophylactic treatment for migraineurs based on level of severity (i.e., mild, moderate, severe) Effective date: August, 2007 Page 1

Effective date: August, 2007 Page 2

Effective date: August, 2007 Page 3

Effective date: August, 2007 Page 4

Drug Notes Side Effects Contraindications Acetaminophen Hypersensitivity to acetaminophen Acetaminophen / Aspirin/Caffeine Acetominophen/aspirin mix with caffeine added Aspirin Gastrointestinal * Active peptic ulcer Chlorpromazine (CPZ) injection Thorazine Dexamethasone Decadron DHE (dihydroergotamine mesylate) D.H.E. 45 Type of tranquilizer and anti-psychotic medication used to treat migraines and nausea Anti-inflammatory and steroid medication Type of drug used to treat migraine, rebound, or cluster headaches Drowsiness, extrapyramidal * symptoms Cushingoid * Chest tightness, tingling, nausea disease Hypotension *, previous adverse reaction Ischemic heart disease *, uncontrolled hypertension *, vasospastic angina *, advanced peripheral vascular disease *, pregnancy, ischemic cerebrovascular disease * Nasal spray Migranal Ergotamine by mouth Cafergot Type of drug used to treat migraine, rebound, or cluster headaches, constricts blood vessels, improves blood vessel tone Nasal congestion, throat discomfort, nasal irritation, nausea Chest pain, tingling, nausea See DHE * injection Ischemic heart disease *, uncontrolled hypertension *, vasospastic angina *, advanced peripheral vascular disease *, pregnancy, ischemic cerebrovascular disease * Rectal suppository Cafergot Chest pain, tingling, nausea See Ergotamine by mouth Sublingual (under the tongue) Ergomar Hydrocortisone Solu-Cortef Anti-inflammatory and steroid medication Chest pain, tingling, nausea See Ergotamine by mouth Effective date: August, 2007 Page 5

Drug Notes Side Effects Contraindications Isometheptene Mucate 65 mg / Dichloralphenazone 100 mg/ Acetaminophen 325 mg Midrin CIV Type of sedative and combination drug use to treat migraine and tension headache Drowsiness, dizziness Ischemic heart disease *, severe renal disease *, ischemic cerebrovascular disease* Ketorolac IM (inject into the muscle) Toradol Lidocaine 4% Solution * Magnesium Sulfate Opiates Hydromorphone Dilaudid Morphine NSAID (non-steroidal anti-inflammatory) Local anesthetic Electrolyte replenisher and anticonvulsant for treatment of acute (sudden) migraine. Affects muscle constriction and nerve transmission. Type of drug that depresses the central nervous system and used to relieve pain Drowsiness, nausea, dyspepsia * Burning or numbness in nose or pharynx * Flushing, hypotension*, burning sensation in the face and neck Sedation, confusion, risk of habituation Active peptic ulcer disease *, renal insufficiency * Heart block *, severe renal impairment * Meperidine HCL Demerol NSAIDs Ibuprofen Advil Motrin Nuprin Non-steroidal antiinflammatory drug Gastrointestinal * Active peptic ulcer disease *, renal insufficiency * Ketoprofen Orudis K Actron Naproxen Sodium Anaprox Aleve Prochlorperazine IV Compazine Valproate Sodium Depacon Antiemetic (stops nausea or vomiting) Type of antiepileptic medication Gastrointestinal * Gastrointestinal * Drowsiness, extrapyramidal symptoms * Nausea, vomiting, tremor, dizziness See Ibuprofen See Ibuprofen Hypotension * Liver disease, pregnancy Effective date: August, 2007 Page 6

Drug Notes Side Effects Contraindications 5-HT Agonists (Triptans) Almotriptan Axert Eletriptan Relpax Frovatriptan Frova Naratriptan Amerge Rizatriptan Maxalt Mazalt MLT Sumatriptan Imitrex by mouth Nasal spray Subcutaneous (inject into the skin) Zolmitriptan Zomig Zomig-ZMT by mouth Medications specific to the treatment of migraine and cluster headaches Tingling, nausea, dry mouth, drowsiness, chest tightness (26% of time) Dizziness, drowsiness, nausea, dry mouth, paresthesia *, chest/abdominal tightness, vomiting, dysphagia * Chest tightness, flushing, dizziness, tingling, fatigue Chest/throat tightness, tingling, flushing, dizziness, nausea Chest/throat tightness, dizziness, tingling Chest tightness, tingling, flushing, dizziness, limb heaviness, nausea Chest/throat tightness Chest/throat tightness Chest/throat tightness, tingling, flushing, dizziness, nausea Not to be used within 72 hours of treatment with the following potent CYP3A4 inhibitors: ketocomazole, itracomazole, mefazodome, troleandomycin, clarithromycin, ritomavir, nelfinavir Hypertension*, vasospastic angina*, peripheral vascular disease*, pregnancy, ischemic cerebrovascular disease*, use of other 5-HT agonists* or ergotamines* if used within 24 hours Ischemic heart disease*, uncontrolled hypertension*, vasospastic angina*, peripheral vascular disease*, pregnancy, ischemic cerebrovascular disease*, use of 5-HT agonists* or ergotamines* if used within 24 hours, use of MAO inhibitors* within 2 weeks Nasal spray Effective date: August, 2007 Page 7

Drug Notes Side Effects Contraindications Antiepileptics Divalproex Sodium (valponate sodium) Depakote Depakote-ER (time release) Anti epileptic and anticonvulsant drugs Nausea, tremor, weight gain, alopecia*, increased LFTs* Avoid in patients with liver disease, pregnancy Gabapentin Neurontin Dizziness, somnolence*, peripheral edema*, fatigue, ataxia*, nervousness, tremor, weight gain Topiramate Topamax Beta-Blockers Atenolol Tenormin Metoprolol Lopressor Heart medication Somnolence*, nervousness, fatigue, dizziness, confusion, anorexia*, ataxia*, acute-angle closure of glaucoma*, nausea, metabolic acidosis*, paresthesias*, kidney stones Fatigue, bronchospasm*, bradycardia*, hypotension*, CHF*, depression, impotence*, decreased libido*, sleep disturbance Reduced renal* or hepatic* functions Sinus bradycardia*, 1 st degree heart block*, acute CHF* Nadolol Corgard Propranolol Inderal Timolol Blocadren Ca+ Channel Blockers Verapamil Calan Veselan Muscle relaxants Tizanidine Zanaflex Tricyclics Amitiptyline Elavil Heart medication Muscle relaxants Constipation, dizziness, edema*, hypotension*, nausea Dry mouth, drowsiness, asthesia*, dizziness, mild hypotension* Atrial fibrillation*, CHF*, sick sinus syndrome*, hypotension*, 2 nd, 3 rd degree heart block* Doxepin Sinequan Nortiptyline Aventyl Pamelor Effective date: August, 2007 Page 8